Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Ambient AI Documentation in Oncology Consultations

NCT: NCT07850700 · NOT_YET_RECRUITING

NCT IDNCT07850700
StatusNOT_YET_RECRUITING
Start Date2026-11-01
Completion2027-12-31
SponsorNational Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos (OTHER)
First posted
Last updated

Brief Summary

This study tests whether an artificial intelligence (AI) system can help doctors write medical notes during cancer consultations. After a cancer patient is seen by a multidisciplinary team (a group of specialists who decide on the best treatment), they have a consultation with their oncologist to discuss the treatment plan. During this consultation, doctors must write detailed medical notes, which takes significant time and effort. In this study, an ambient AI system called VOCALI is used during oncology consultations at the National Cancer Center in Vilnius, Lithuania. Before the consultation begins, the doctor loads relevant pseudonymized clinical data from the electronic health record (such as diagnosis and treatment plan) into the system. During the consultation, VOCALI records the conversation (with the patient's consent) and combines it with the loaded clinical data to automatically generate a draft medical note in Lithuanian. Patients may ask the doctor to stop the recording at any time. The doctor then reviews the draft, makes any necessary corrections, and approves the final document. The AI does not make any medical decisions - the doctor is always responsible for the final note. What the study measures: The study has three main goals: * To assess the quality of the AI-generated notes, rated by two independent reviewers using the PDQI-10, a standardized documentation quality instrument translated into Lithuanian using forward-backward translation * To measure the time doctors spend reviewing and approving the AI-generated draft * To monitor safety - whether any AI errors could affect patient care The study also collects information on doctor workload, ease of use of the system, and patient satisfaction with the consultation. Who can participate: Adult patients (age 18 or older) attending a primary oncology consultation at the National Cancer Center in Vilnius, Lithuania, after a multidisciplinary team decision, who speak Lithuanian and provide written consent. Study details: 250 patients will be enrolled over 12 months. Each participant attends one consultation and completes a short satisfaction questionnaire (about 5 minutes). No additional visits are required. There is no comparator group - all participants receive the AI-assisted documentation. This is the first study to evaluate ambient AI documentation in the Lithuanian language and in the Lithuanian oncology setting.

Frequently Asked Questions

What is Ambient AI Documentation in Oncology Consultations?

Ambient AI Documentation in Oncology Consultations is a clinical trial registered under NCT07850700. Current status: NOT_YET_RECRUITING.

What is the status of NCT07850700?

The current status of NCT07850700 (Ambient AI Documentation in Oncology Consultations) is: NOT_YET_RECRUITING.

When did Ambient AI Documentation in Oncology Consultations start?

Ambient AI Documentation in Oncology Consultations started on 2026-11-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑